Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 201,400 | 507,600 | 204,554 | 154,171 | 467,451 |
| Marketable Securities | 13,600 | 13,200 | 11,799 | 6,649 | 152,467 |
| Receivables | 517,400 | 305,000 | 267,117 | 384,692 | 333,832 |
| Inventories | 692,300 | 473,100 | 490,601 | 517,236 | 278,062 |
| Income taxes - deferred | 130,900 | 111,000 | 113,633 | 112,813 | 90,717 |
| TOTAL | $1,769,500 | $1,458,400 | $1,173,776 | $1,261,676 | $1,353,543 |
| Non-Current Assets | |||||
| PPE Net | 694,200 | 658,500 | 688,185 | 697,415 | 436,149 |
| Investments And Advances | 114,500 | 80,600 | 68,034 | 76,377 | 54,359 |
| Intangibles | 3,214,500 | 1,428,100 | 1,480,146 | 1,669,761 | 1,207,403 |
| Other Non-Current Assets | 110,800 | 52,300 | 61,886 | 55,348 | 25,733 |
| TOTAL | $4,134,000 | $2,219,500 | $2,298,251 | $2,498,901 | $1,723,644 |
| Total Assets | $5,903,500 | $3,677,900 | $3,472,027 | $3,760,577 | $3,077,187 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 307,600 | 53,200 | 6,241 | 107,059 | N/A |
| Accounts payable and accrued liabilities | 614,300 | 381,300 | 398,154 | 516,875 | 211,160 |
| TOTAL | $1,047,900 | $482,000 | $444,927 | $689,929 | $245,670 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,150,200 | 824,700 | 899,408 | 1,124,145 | 587,935 |
| Deferred Revenues | 16,300 | 16,100 | 21,754 | 19,222 | 5,721 |
| aiOther Non-Current Liabilities | 194,700 | 58,200 | 59,952 | 4,169 | 2,504 |
| TOTAL | $1,832,500 | $1,087,300 | $1,177,635 | $1,390,260 | $731,048 |
| Total Liabilities | $2,880,400 | $1,569,300 | $1,622,562 | $2,080,189 | $976,718 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,516 | 104,627 | 103,658 | 102,501 | 111,030 |
| Common Shares | 400 | 400 | 373 | 369 | 367 |
| Retained earnings | 1,640,100 | 1,418,100 | 1,179,737 | 1,041,638 | 1,486,643 |
| Other shareholders' equity | 1,700 | -2,800 | 2,616 | 1,073 | -10,160 |
| TOTAL | $3,023,100 | $2,108,600 | $1,849,465 | $1,680,388 | $2,100,469 |
| Total Liabilities And Equity | $5,903,500 | $3,677,900 | $3,472,027 | $3,760,577 | $3,077,187 |